Q1 2025 Beiersdorf AG Earnings Call Transcript
Key Points
- Beiersdorf AG (BDRFF) achieved a 2.3% organic sales growth in the consumer segment, despite a challenging prior year comparison.
- The Derma brands, Eucerin and Aquaphor, reported strong double-digit organic sales growth of 11.4%, driven by successful innovations and market expansions.
- The healthcare business, including Hansaplast and Elastoplast, experienced a 10.8% sales growth, supported by new product launches.
- Tesa division recorded an impressive 10.7% organic sales growth, bolstered by a strong performance in the electronics segment.
- The company is strategically repositioning in China, focusing on skincare and digital channels, setting the foundation for future growth.
- Sales of La Prairie declined by 17.5% due to challenges in China and the travel retail market, necessitating destocking activities.
- The repositioning efforts in China negatively impacted NIVEA's results, contributing to a slower growth rate in the region.
- The automotive market continues to pose challenges for Tesa, with recent tariff developments adding further complications.
- The consumer business in the Africa, Asia, Australia region was significantly affected by repositioning measures in China, resulting in lower growth.
- Beiersdorf AG (BDRFF) faces uncertainties in the global economy, including geopolitical tensions and tariff policies, which could impact consumer confidence and business performance.
Ladies and gentlemen, welcome to the Q1 Beiersdorf 2025 result conference call. I am Yusuf, the chorus call operator.
(Operator Instructions) This conference is being recorded.
(Operator Instructions) At this time, it's my pleasure to hand over to Christopher Sheldon, Head of Investor Relations. Please go ahead.
Thank you, Yusuf. Good morning and welcome to Beiersdorf's first quarter conference call. Thank you for joining us today. I'm here with our CEO, Vincent Warnery, as well as our CFO, Astrid Hermann.
We would like to share with you Beiersdorf's sales performance of the first three months of 2025. We will start with the presentation of our results followed by a Q&A session.
And with that, I'd like to hand over to Vincent.
Thank you, Christopher, and good morning. Welcome to today's conference call. Astrid and I will
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
